ADIM
CE icon

Alpha DNA Investment Management’s Celanese CE Stock Holding History

Alpha DNA Investment Management’s Portfolio CE Stock Details CE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,488
Closed -$224K – 154
2022
Q3 		$224K Sell
2,488
-8,165
-77% -$897K 0.19% 145
2022
Q2 		$1.25M Buy
+10,653
New +$1.53M 1.07% 6

Other funds holding CE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alpha DNA Investment Management's CE Position: Q4 2022 in Review

Alpha DNA Investment Management sold out of Celanese (CE) in Q4 2022, closing a stake of 2,488 shares — an estimated $224K sold.

Alpha DNA Investment Management first reported a position in CE in Q2 2022 and held it in 2 quarters. The position peaked at $1.25M in Q2 2022. 650 funds tracked by Wall St. Rank hold CE as of Q4 2022.

  • Alpha DNA Investment Management reported no remaining Celanese position as of Q4 2022 after selling out during the quarter.
  • Alpha DNA Investment Management sold 2,488 Celanese shares in Q4 2022, an estimated $224K.
  • Alpha DNA Investment Management first reported a position in Celanese in Q2 2022 and held it in 2 quarters.
  • Alpha DNA Investment Management's Celanese position peaked at $1.25M in Q2 2022.
  • 650 funds tracked by Wall St. Rank held Celanese as of Q4 2022.

Based on Alpha DNA Investment Management's 13F filing for Q4 2022, filed 27 Jan 2023.